Institutional investors purchased a net $556.1 thousand shares of DXCM during the quarter ended June 2017 and now own 117.14% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HENDERSON GLOBAL INVESTORS LTD. Bought 2.0 Million shares of DexCom Inc
AXA INVESTMENT MANAGERS UK LTD. Bought 332.2 Thousand shares of DexCom Inc